Potential Direct Cardiovascular Effects: While the primary mechanisms of cardiovascular benefit are likely mediated through weight loss and metabolic improvements, some preclinical and early clinical data suggest that GLP-1 receptor agonists, and potentially GIP receptor agonists, may have direct effects on the heart and blood vessels, such as reducing inflammation and improving endothelial function
The role of protein in weight loss and maintenance
Experience the benefits of IV therapy, including enhanced hydration, enhanced energy levels, improved immune function, detoxification support, and a sense of calm and well-being
Cagrilintide is under development as a monotherapy for the treatment of overweight and obesity and as a fixed-dose combination with the glucagon-like peptide-1 receptor agonist semaglutide (CagriSema) for the treatment of overweight, obesity and type 2 diabetes [4] with the rationale that the two molecules may have complementary effects on appetite and glucose regulation
20.7 A child with McCune-Albright syndrome presents with a large, sharply defined tan patch with jagged border 20.6.2 Histology The most common cutaneous manifestation in patients with McCune-Albright syndrome is that of pigmented lesions that are clinically and histologically indistinguishable from caf au lait macules
